Research Summary
Adipotide
Adipotide is a peptide studied in preclinical research for its effects on adipose tissue vasculature.
Being studied for
Published Research
Evidence profile
Preclinical, with limited uncontrolled human reports
6 cited publications
Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.
Additional indexed literature (6)
- Clinical · Mechanistic studyProhibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
El-Etreby NM et al. · Journal of ovarian research · 2017 · PMID 28427435
- Clinical · Mechanistic studyA peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys
Barnhart KF et al. · Science translational medicine · 2011 · PMID 22072637
- Clinical · Mechanistic studyReversal of obesity by targeted ablation of adipose tissue
Kolonin MG et al. · Nature medicine · 2004 · PMID 15133506
- Preclinical · Mechanistic studyFatty Liver/Adipose Tissue Dual-Targeting Nanoparticles with Heme Oxygenase-1 Inducer for Amelioration of Obesity, Obesity-Induced Type 2 Diabetes, and Steatohepatitis
Hong J et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022 · PMID 36209391
- Preclinical · Mechanistic studyA comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
Hossen N et al. · Journal of controlled release : official journal of the Controlled Release Society · 2013 · PMID 23871959
- Preclinical · Mechanistic studyAdipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
Liu J et al. · Endocrine journal · 2011 · PMID 21325744
Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Lucid Peptides material. Citations verified against PubMed on 2026-08-09.